Single versus combination pneumococcal conjugate vaccines (13PCV and PHiD-CV) for high-risk Aboriginal children (COMBO)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/605810

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Two new pneumococcal vaccines, each offering protection from different pneumococcal strains and pathogens will soon be available. At this time, health experts do not know which vaccine will be best for Indigenous children. The hypothesis of this project is that both vaccines, given as a 4 dose schedule may be a better than 3-dose single vaccines for Indigenous and high-risk children. The vaccines' effects on immune response and on nasal colonisation with bacterial pathogens will be compared.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2014

Funding Scheme: NHMRC Project Grants

Funding Amount: $3,017,464.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Aboriginal and Torres Strait Islander Health

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Indigenous child health | Pneumonia | Public Health | Randomised controlled trial | Vaccines | immune response | microbiology | otitis media | vaccines

Related Links